United Therapeutics Corporation
USD540.13
-4.79 (-0.88%)
CEO
Martine A. Rothblatt
IPO Date
1999-06-17
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$547.42
Prev. Close
$544.92
Day Low
$535.67
Day High
$552.46
52W Low
$272.12
52W High
$609.35
Market Cap
$22.93B
Volume
0.12M
| 684 |
| $543.54 |
| 26 Jun 2026 | ROTHBLATT MARTINE A | director, officer: Chairperson & CEO | S-Sale | Disposed | 418 | $545.08 |
| 26 Jun 2026 | ROTHBLATT MARTINE A | director, officer: Chairperson & CEO | S-Sale | Disposed | 301 | $546.38 |
| 26 Jun 2026 | ROTHBLATT MARTINE A | director, officer: Chairperson & CEO | S-Sale | Disposed | 441 | $547.87 |
| 26 Jun 2026 | ROTHBLATT MARTINE A | director, officer: Chairperson & CEO | S-Sale | Disposed | 645 | $548.77 |
| 26 Jun 2026 | ROTHBLATT MARTINE A | director, officer: Chairperson & CEO | S-Sale | Disposed | 762 | $549.55 |
| 26 Jun 2026 | ROTHBLATT MARTINE A | director, officer: Chairperson & CEO | S-Sale | Disposed | 1,617 | $550.86 |
| 26 Jun 2026 | ROTHBLATT MARTINE A | director, officer: Chairperson & CEO | S-Sale | Disposed | 1,814 | $551.61 |
| 26 Jun 2026 | ROTHBLATT MARTINE A | director, officer: Chairperson & CEO | S-Sale | Disposed | 1,778 | $552.68 |
| 18 Apr 2022 | Michael McCaul | Michael McCaul | Purchase | $15,001 - $50,000 |
| 18 Apr 2022 | Michael McCaul | Michael McCaul | Purchase | $1,001 - $15,000 |
| 23 Feb 2022 | Michael McCaul | Michael McCaul | Sale | $1,001 - $15,000 |
| 23 Feb 2022 | Michael McCaul | Michael McCaul | Sale | $15,001 - $50,000 |
| 27 Apr 2020 | Donna Shalala | Donna Shalala | Sale (Full) | $1,001 - $15,000 |